MBL(CycLex & CircuLex)/CircuLex Human PCSK9 ELISA Kit/CY-8079/96 assays

价格
¥9083.15
货号:CY-8079
浏览量:127
品牌:MBL
服务
全国联保
正品保证
正规发票
签订合同
商品描述
ComponentsMicroplate,WashBuffer,DilutionBuffer,PCSK9Standard,HRPconjugatedDetectionAntibody,SubstrateReagent,StopSolution
IntendeduseThisKitisusedforthequantitativemeasurementofHumanPCSK9inserum,plasma,cellculturemediumandotherBIOLOGicalmedia.
Storagetemp.4°CManufacturerMBL
Animalspecies
[GeneID]
Human
SampleSerum,Plasma,Cellculturemedium,Otherbiologicalmedia
Measurementrange0.16~10ng/mL
Sensitivity0.154ng/mL~
Citations
  1. NoguchiTetal.TheE32KvariantofPCSK9exacerbatesthephenotypeoffamilialhypercholesterolaemiabyincreasingPCSK9functionandconcentrationinthecirculation.Atherosclerosis210,166-172(2010)(PMID:20006333)
  1. CariouBetal.AssociationbetweenplasmaPCSK9andgamma-glutamyltransferaselevelsindiabeticpatients.Atherosclerosis211,700-702(2010)(PMID:20452593)
  1. CostetPetal.PlasmaPCSK9isincreasedbyFenofibrateandAtorvastatininanonadditivefashionindiabeticpatients.Atherosclerosis212,246-251(2010)(PMID:20619837)
  1. NoguchiTetal.Comparisonofeffectsofbezafibrateandfenofibrateoncirculatingproproteinconvertasesubtilisin/kexintype9andADIpocytokinelevelsindyslipidemicsubjectswithimpairedglucosetoleranceortype2diabetesmellitus:Resultsfromacrossoverstudy.Atherosclerosis217,165-70(2011)(PMID:21411093)
  1. MayneJetal.NovelLoss-of-FunctionPCSK9VariantIsAssociatedwithLowPlasmaLDLCholesterolinaFrench-CanadianFamilyandwithImpairedProcessingandSecretioninCellCulture.ClinChem.57,1415(2011)(PMID:21813713)
  1. VergèsBetal.LackofassociationbetweenplasmaPCSK9andLDL-apoB100catabolisminpatientswithuncontrolledtype2diabetes.Atherosclerosis.219,342-8(2011)(PMID:21889145)
  1. LenaPersson.StudiesonPCSK9intheregulationofcholesterolmetabolism.PublishedbyKarolinskaInstitutet.Stockholm2011
  1. CariouBetal.ClinicalaspectsofPCSK9.Atherosclerosis.216,258-65(2011)(PMID:21596380)
  1. PerssonLetal.EndogenousEstrogensLowerPlasmaPCSK9andLDLCholesterolButNotLp(a)orBileAcidSynthesisinWomen.ArteriosclerThrombVascBiol.32,810-4(2011)(PMID:22207727)
  1. KawashiriMAetal.EfficacyandSafetyofCoadmiNISTrationofRosuvastatin,Ezetimibe,andColestimideinHeterozygousFamilialHypercholesterolemia.AmJCardiol.109,364-9(2011)(PMID:22112743)
  1. LindholmMWetal.PCSK9LNAAntisenseOligonucleotidesInduceSustainedReductionofLDLCholesterolinNonhumanPrimates.MolTher.20,376-81(2012)(PMID:22108858)
  1. CameronJetal.Serumlevelsofproproteinconvertasesubtilisin/kexintype9insubjectswithfamilialhypercholesterolemiaindicatethatproproteinconvertasesubtilisin/kexintype9isclearedfromplasmabylow-densitylipoproteinreceptor_independentpathways.TranslationalResearch.160,125-30(2012)(PMID:22683370)
  1. HuijgenRetal.PlasmalevelsofproproteinconvertasesubtilisinKexintype9(PCSK9)andphenotypicvariABIlityinfamilialhypercholesterolemia.JLipidRes.53,979-83(2012)(PMID:22375030)
  1. CariouBetal.PlasmaPCSK9concentrationsduringanoralfatloadandaftershorttermhigh-fat,high-fathigh-proteinandhigh-fructosediets.NutrMetab.10,4(2013)(PMID:23298392)
  1. LeeCJetal.Associationofserumproproteinconvertasesubtilisin/kexintype9withcarotidintimamediathicknessinhypertensivesubjects.Metabolism.62,845-50(2013)(PMID:23380568)
  1. LeBrasMetal.PlasmaPCSK9isalatebioMarkerofseverityinpatientswithseveretraumainjury.JClinEndocrinolMetab.98,E732-6(2013)(PMID:23450051)
  1. MayneJetal.DifferentialeffectsofPCSK9lossoffunctionvariantsonserumlipidandPCSK9levelsinCaucasianandAfricanCanadianpopulations.LipidsHealthDis.12,70(2013)(PMID:23663650)
  1. PeticcaPetal.HumanSerumPCSK9IsElevatedatParturitioninComparisontoNonpregnantSubjectsWhileSerumPCSK9fromUmbilicalCordBloodisLowerComparedtoMaternalBlood.ISRNEndocrinol.2013,341632(2013)(PMID:23862071)
  1. TremblayAJetal.Short-term,high-fatdietincreasestheexpressionofkeyintestinalgenesinvolvedinlipoproteinmetabolisminhealthymen.AmJClinNutr.98,32-41(2013)(PMID:23719552)
  1. ConwayVetal.Impactofbuttermilkconsumptiononplasmalipidsandsurrogatemarkersofcholesterolhomeostasisinmenandwomen.NutrMetabCardiovascDis.23,1255-62(2013)(PMID:23786821)
  1. LambertGetal.ElevatedplasmaPCSK9levelisequallydetrimentalforpatientswithnonfamilialhypercholesterolemiaandheterozygousfamilialhypercholesterolemia,irrespectiveoflow-densitylipoproteinreceptordefects.JAmCollCardiol.63,2365-73(2014)(PMID:24632287)
  1. WernerCetal.Riskpredictionwithproproteinconvertasesubtilisin/kexintype9(PCSK9)inpatientswithstablecoronarydiseaseonstatintreatment.VasculPharmacol.62,94-102(2014)(PMID:24685817)
  1. AbujradHetal.ChronickidneydiseaseonhemodialysisisassociatedwithdecreasedserumPCSK9levels.Atherosclerosis.233,123-9(2014)(PMID:24529132)
  1. JiaYJetal.Short-andlong-termeffectsofXuezhikang(),anextractofcholestin,onserumproproteinconvertasesubtilisin/kexintype9levels.ChinJIntegrMed.(2014)(PMID:24993334)
  1. BondeYetal.ThyroidhormonereducesPCSK9andstimulatesbileacidsynthesisinhumans.JLipidRes.55,2408-15(2014)(PMID:25172631)
  1. MbikayMetal.Quercetin-3-glucosideincreaseslow-densitylipoproteinreceptor(LDLR)expression,attenuatesproproteinconvertasesubtilisin/kexin9(PCSK9)secretion,andstimulatesLDLuptakebyHuh7humanhepatocytesinculture.FEBSOpenBio.4,755-62(2014)(PMID:25349780)
  1. IggmanDetal.Roleofdietaryfatsinmodulatingcardiometabolicriskduringmoderateweightgain:arandomizeddouble-blindoverfeedingtrial(LIPOGAINstudy).JAmHeartAssoc.3,e001095(2014)(PMID:25319187)
  1. XuRXetal.RelationofplasmaPCSK9levelstolipoproteinsubfractionsinpatientswithstablecoronaryarterydisease.LipidsHealthDis.13,188(2014)(PMID:25496400)
  1. GhoshMetal.InfluenceofphysiologicalchangesinendogenousestrogenoncirculatingPCSK9andLDLcholesterol.JLipidRes.56,463-9(2015)(PMID:25535288)
  1. XuRXetal.ImpactsofezetimibeonPCSK9inrats:studyontheexpressionindifferentorgansandthepotentialmechanisms.JTranslMed.13,87(2015)(PMID:25889684)
  1. StarrAEetal.β-Estradiolresultsinaproproteinconvertasesubtilisin/kexintype9-dependentincreaseinlow-densitylipoproteinreceptorlevelsinhumanhepaticHuH7cells.FEBSJ.282,2682-96(2015)(PMID:25913303)
  1. RosqvistFetal.Potentialroleofmilkfatglobulemembraneinmodulatingplasmalipoproteins,geneexpression,andcholesterolmetabolisminhumans:arandomizedstudy.AmJClinNutr.102,20-30(2015)(PMID:26016870)
  1. ButkinareeCetal.AmyloidPrecursor-likeProtein2andSortilinDoNotRegulatethePCSK9Convertase-mediatedLowDensityLipoproteinReceptorDegradationbutInteractwithEachOther.JBiolChem.290,18609-20(2015)(PMID:26085104)
  1. vanPelgeestEPetal.Antisense-mediatedreductionofproproteinconvertasesubtilisin/kexintype9(PCSK9):afirst-in-humanrandomized,placebo-controlledtrial.BrJClinPharmacol.80,1350-61(2015)(PMID:26261033)
  1. WassefHetal.TheapoB-to-PCSK9ratio:Anewindexformetabolicriskinhumans.JClinLipidol.9,664-75(2015)(PMID:26350813)
  1. Si-TayebKetal.Urine-sample-derivedhumaninducedpluripotentstemcellsasamodeltostudyPCSK9-mediatedautosomaldominanthypercholesterolemia.DisModelMech.9,81-90(2016)(PMID:26586530)
  1. RogacevKSetal.PCSK9PlasmaConcentrationsAreIndependentofGFRandDoNotPredictCardiovascularEventsinPatientswithDecreasedGFR.PLoSOne11,e0146920(2016)(PMID:26799206)
  1. MiasanAetal.EffectsofLDLReceptorModulationonLymphaticFunction.SciRep.6,27862(2016)(PMID:27279328)
  1. VlachopopulosCetal.Predictionofcardiovasculareventswithlevelsofproproteinconvertasesubtilisin/kexintype9:Asystematicreviewandmeta-analysis.Atherosclerosis.252,50-60(2016)(PMID:27501130)
  1. LiSetal.Novelcirculatinglipidmeasurementsforcurrentdyslipidemiasinnon-treatedpatientsundergoingcoronaryangiography:PCSK9,apoC3andsdLDL-C.Oncotarget8,12333-12341(2017)(PMID:27713142)
  1. NavareseEPetal.AssociationofPCSK9withplateletreactivityinpatientswithacutecoronarysyndrometreatedwithprasugrelorticagrelor:ThePCSK9-REACTstudy.IntJCardiol.227,644-649(2017)(PMID:27810295)
  1. SuzukiYetal.BiodegradablelipidnanoparticlesinduceaprolongedRNAinterference-mediatedproteinknockdownandshowrapidhepaticclearanceinmiceandnonhumanprimates.IntJPharm.519,34-43(2017)(PMID:28089936)
  1. LiSetal.Novelandtraditionallipid-relatedbiomarkersandtheircombinationsinpredictingcoronaryseverity.SciRep.7,360(2017)(PMID:28336922)
  1. HyrinaAetal.Treatment-InducedViralCureofHepatitisCVirus-InfectedPatientsInvolvesaDynamicInterplayamongthreeImportantMolecularPlayersinLipidHomeostasis:CirculatingmicroRNA(miR)-24,miR-223,andProproteinConvertaseSubtilisin/KexinType9.EBioMedicine.23,68-78(2017)(PMID:28864162)
  1. BlanchardCetal.Roux-en-Ygastricbypassreducesplasmacholesterolindiet-inducedobesemicebyaffectingtrans-intestinalcholesterolexcretionandintestinalcholesterolabsorption.IntJObes.(2017)Inpress.(PMID:29135972)
Productcategory
Researcharea
Metabolism
Drugdiscovery
MBL抗体(28)夹代号产品数据数据表同型克隆共轭尺寸价钱可用性应用反应性储存温度BMP064抗SLC22A12(URAT1)(人类)pAb 1个23上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9FCM / IC / IH胡-20°摄氏度BMP011抗SLC7A5(LAT1)(人类)pAb 1个2上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上WB / IH胡-20°摄氏度BMP052抗SLC6A14(ATB 0+)(人)多株抗体 1个234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP007抗SLC2A1(GLUT1)(人类)pAb 1个2上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上WB / IH胡-20°摄氏度BMP079抗SLC17A9亚型2(VNUT)(人类)pAb 1个2上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上FCM / IH胡/莫* /鼠*-20°摄氏度BMP027抗SLC2A9(GLUT9)(人类)pAb 1个234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9WB / FCM / IC / IH胡-20°摄氏度BMP026抗SLC2A13(HMIT)(人类)pAb 1个234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9WB / FCM / IC / IH胡-20°摄氏度BMP081抗SLC38A2(SNAT2)(人类)pAb 1个23上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,0001-9WB / FCM / IC / IH胡-20°摄氏度BMP046抗SLC6A6(TAUT)(人类)pAb 1个23上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB * / FCM / IC / IH胡/其他*-20°摄氏度BMP023抗SLC9A1(NHE1)(人类)pAb 1个234上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP041抗SLC7A8(LAT2)(人类)pAb 1个234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP040抗SLC7A3(CAT3)(人类)pAb 1个234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9WB / FCM / IC / IH胡-20°摄氏度BMP045抗SLC6A4(SERT)(人类)pAb 1个2上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9WB / IH胡-20°摄氏度BMP053抗SLC6A19(B 0 AT1)(人类)pAb 1个23上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上FCM / IC / IH胡-20°摄氏度BMP033抗SLC40A1(FPN1)(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP029抗SLC6A2(NET)(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP043抗SLC9A7(NHE7)(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP028抗SLC1A4(ASCT1)(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9WB / FCM / IC / IH胡-20°摄氏度BMP091抗SLC6A9(GlyT1)(人类)pAb 123上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上WB / FCM / IH胡-20°摄氏度BMP098抗SLC43A1(LAT3)(人类)pAb 12上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上WB / IH胡-20°摄氏度BMP048抗SLC18A3(VAChT)(人类)pAb 12上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9FCM / IH胡-20°摄氏度BMP021抗SLC7A9(B 0 / + AT)(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度BMP031抗SLC16A2(MCT8)(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,0001-9WB / FCM / IC / IH胡-20°摄氏度BMP071抗SLC4A10(NCBE)(人类)pAb 123上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,00010以上FCM / IC / IH胡-20°摄氏度BMP012抗SLC4A1(AE1)(人类)pAb 12上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,0001-9WB / IH胡-20°摄氏度BMP069抗SLC1A2(EAAT2)(人类)pAb 123上一个下一个兔Ig(aff。)多克隆的未贴标签100微升¥ 60,0001-9FCM / IC / IH胡-20°摄氏度BMP050抗SLC6A15(SBAT1)(人类)pAb 123上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上FCM / IC / IH胡-20°摄氏度BMP042抗SLC7A14(人类)pAb 1234上一个下一个兔Ig(aff。)多克隆的未贴标签50微升¥ 60,00010以上WB / FCM / IC / IH胡-20°摄氏度